301 related articles for article (PubMed ID: 12689679)
1. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.
Papachristou DJ; Batistatou A; Sykiotis GP; Varakis I; Papavassiliou AG
Bone; 2003 Apr; 32(4):364-71. PubMed ID: 12689679
[TBL] [Abstract][Full Text] [Related]
2. The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF.
Papachristou DJ; Papachristou GI; Papaefthimiou OA; Agnantis NJ; Basdra EK; Papavassiliou AG
Histopathology; 2005 Dec; 47(6):565-74. PubMed ID: 16324193
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
Kieser A; Kilger E; Gires O; Ueffing M; Kolch W; Hammerschmidt W
EMBO J; 1997 Nov; 16(21):6478-85. PubMed ID: 9351829
[TBL] [Abstract][Full Text] [Related]
4. AP-1 and heat shock protein 27 expression in human astrocytomas.
Assimakopoulou M; Varakis J
J Cancer Res Clin Oncol; 2001 Dec; 127(12):727-32. PubMed ID: 11768612
[TBL] [Abstract][Full Text] [Related]
5. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
6. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
7. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids.
Olazabal I; Muñoz J; Ogueta S; Obregón E; García-Ruiz JP
Mol Endocrinol; 2000 Apr; 14(4):564-75. PubMed ID: 10770493
[TBL] [Abstract][Full Text] [Related]
8. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
9. Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription.
Moreau A; Yotov WV; Glorieux FH; St-Arnaud R
Mol Cell Biol; 1998 Mar; 18(3):1312-21. PubMed ID: 9488446
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases.
Benn J; Su F; Doria M; Schneider RJ
J Virol; 1996 Aug; 70(8):4978-85. PubMed ID: 8764004
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin.
Gründker C; Schlotawa L; Viereck V; Emons G
Eur J Endocrinol; 2001 Nov; 145(5):651-8. PubMed ID: 11720885
[TBL] [Abstract][Full Text] [Related]
12. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
13. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton.
Franchi A; Calzolari A; Zampi G
Virchows Arch; 1998 Jun; 432(6):515-9. PubMed ID: 9672192
[TBL] [Abstract][Full Text] [Related]
15. Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons.
Chihab R; Ferry C; Koziel V; Monin P; Daval JL
Brain Res Mol Brain Res; 1998 Dec; 63(1):105-20. PubMed ID: 9838068
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
17. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells.
Faris M; Ensoli B; Stahl N; Yancopoulos G; Nguyen A; Wang S; Nel AE
AIDS; 1996 Apr; 10(4):369-78. PubMed ID: 8728040
[TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma.
Ricote M; Royuela M; García-Tuñón I; Bethencourt FR; Paniagua R; Fraile B
J Urol; 2003 Sep; 170(3):787-90. PubMed ID: 12913698
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
Delgado M; Ganea D
J Neuroimmunol; 2000 Oct; 110(1-2):97-105. PubMed ID: 11024538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
